CRSP CRISPR Therapeutics Corp: Expected Profit

Public company logo of CRISPR Therapeutics Inc (CRSP)

CRISPR Therapeutics AG (CRSP) brings together leading biologists to develop breakthrough DNA editing methods. The company's future profitability indicator on the GURU.Markets system chart demonstrates a trend where expresses the metric's value today. The commercialization of Casgevy therapy and partnership payments are driving growth, although drug synthesis is automated and final clinical trials require expert physician oversight.

CRISPR Therapeutics AG (CRSP): Forward Earnings from 07/04/2022 to 11/18/2026

CRISPR Therapeutics AG - analytical breakdowns and key metrics (CRSP)

- share price and consensus valuation forecast:
- company stock capitalization data:
Fundamental valuation:CRISPR Therapeutics, CRSP
Brand item of CRISPR

The investment attractiveness of CRISPR Therapeutics AG (CRSP) is based on the potential of gene editing, yet it is coupled with high capital burn and FDA regulatory barriers. This metric aggregates market expectations for future cash flows; therefore, analyzing the business's expected net profit allows for the timely detection of a negative asset overvaluation trend. The dynamics of this indicator determine the fundamental stability of CRISPR Therapeutics AG (CRSP) amid uncertainty regarding the return on investment for its developments.

Competitor analysis for CRISPR Therapeutics AG

Expected Profit Tempus AI|Projected Future Earnings Qiagen|Projected Future Earnings IONS|Expected Profit RGEN (Repligen Corp.)|Avidity - Future Profit|WGS: Net Profit Forecast|ultragenyx.com - Projected Future Earnings|Beam Therapeutics - Future Net Profit|SRPT: Projected Future Earnings|TWST (Twist Bio) - Expected Profit|TXG (10xgenomics.com) - Projected Future Earnings|Projected Future Earnings Intellia Therapeutics, Inc.|Projected Future Earnings STOK|Company Profit Forecast BioLife Solutions Inc|Expected Profit Wave Pharma WVE|Projected Future Earnings Maze Therapeutics Corp MAZE|SION - Expected Profit|Prime Medicine, Inc. (PRME) - Future Profit|TSHA (Taysha Gene Therapies, Inc.) - Future Profit|QURE - Company Profit Forecast|MGTX (MeiraGTx Holdings plc) - Projected Future Earnings|Future Profit REGENXBIO Inc. (RGNX)|Expected Profit Solid Biosciences (SLDB)|ocugen.com (OCGN) - Projected Net Profit|Projected Future Earnings PACB (PacBio Corp)|Expected Net Income BNTC|DSGN: Future Profit|RCKT - Projected Future Earnings|Expected Net Income 4D Molecular Corp FDMT|Future Profit Lexeo|Expected Profit Korro Bio Inc.|Net Profit Forecast EDIT (Editas Medicine)|Expected Profit Silence Therapeutics Corp (SLN)|PRQR (ProQR) - Expected Net Income|Projected Future Earnings CDXS (Codexis, Inc.)|Company Profit Forecast sangamo.com (SGMO)|nautilus.bio - Projected Future Earnings|Metagenomi (MGX) - Future Profit|DTIL: Projected Future Earnings|Expected Net Profit Generation Bio Co (GBIO)|BOLD (Boundless Bio) - Projected Future Earnings|Future Profit Exicure (XCUR)|Expected Profit Celsion Corporation (IMNN)|PHIO - Expected Net Profit|Mustang Bio Inc - Future Profit|Projected Future Earnings transcodetherapeutics.com RNAZ|Bionano Genomics Inc. - Projected Future Earnings|APDN (Applied DNA Sciences) - Net Profit Forecast|BLUE (bluebirdbio.com) - Future Profit|Net Profit Forecast IPA|OMGA (omegatherapeutics.com) - Projected Future Earnings|Singular Genomics Systems Inc (OMIC) - Company Profit Forecast|Projected Future Earnings RGLS|Company Profit Forecast Syros Pharmaceuticals, Inc.|Expected Profit Telesis Bio Inc. TBIO|Future Net Profit TCON (TRACON Pharmaceuticals Inc.)|Unity Bio - Projected Future Earnings